• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Oncology

Keystone Nano launches clinical trial for NanoLiposome cancer therapy

April 7, 2017 By Sarah Faulkner

Keystone Nano launches clinical trial for NanoLiposome cancer therapy

Keystone Nano said today that it has begun clinical testing for its ceramide NanoLiposome cancer therapy. The Phase I trial plans to evaluate the company’s NanoLiposome as a targeted treatment for solid tumors. Ceramide is a lipid that has demonstrated efficacy in liver cancer, breast cancer, leukemia and pancreatic cancer. Preclinical evidence has shown that […]

Filed Under: Clinical Trials, Featured, Nanoparticles, Oncology, Wall Street Beat Tagged With: Keystone Nano

Liposomal drug delivery system could improve solid tumor treatment

April 5, 2017 By Sarah Faulkner

The oxygen-poor regions of solid tumors usually help make them resistant to chemotherapy and other forms of treatment. But researchers at Oregon State University have devised away to take advantage of those hypoxic areas and improve solid tumor treatment with a targeted, liposomal drug delivery system. The team used the cancer drug, vinblastine, which is […]

Filed Under: Featured, Nanoparticles, Oncology, Pharmaceuticals, Research & Development Tagged With: Oregon State University

Study: Nanoparticles could improve efficacy of cancer immunotherapy

April 4, 2017 By Sarah Faulkner

Researchers from the University of North Carolina have discovered that they can potentially improve cancer immunotherapy drugs by binding 2 compounds to a single nanoparticle. The team’s work was presented this week at the annual meeting of the American Association for Cancer Research. “Our data shows that 2 compounds on a single nanoparticle will make […]

Filed Under: Featured, Immunotherapy, Oncology, Research & Development, Wall Street Beat Tagged With: University of North Carolina

Novocure touts long-term data for Optune, chemo combination therapy for glioblastoma

April 3, 2017 By Sarah Faulkner

Novocure

Shares in Novocure (NSDQ:NVCR) jumped nearly 50% today after the company touted 5-year data today from the Phase III pivotal EF-14 trial evaluating its Optune device with temozolomide chemotherapy as a treatment for newly-diagnosed glioblastoma. Data from 695 patients showed a consistent and maintained improvement in overall survival at 2, 3, 4 and 5 years, […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Neurological, Oncology, Wall Street Beat Tagged With: NovoCure

RenovoRx wins label expansion for RenovoCath device

March 31, 2017 By Sarah Faulkner

RenovoRx

RenovoRx said yesterday that it won label expansion for the RenovoCath dual-balloon infusion catheter to include the delivery of chemotherapeutics. The device isolates segments of the peripheral vasculature, allowing doctors to deliver therapeutics in a more targeted fashion, according to the Los Altos, Calif.-based company. “This additional FDA indication marks yet another milestone for RenovoRx as […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Oncology, Regulatory/Compliance Tagged With: RenovoRx

Researchers develop polymer capsules for targeted drug delivery

March 31, 2017 By Sarah Faulkner

Researchers at the University of Alabama at Birmingham have developed cancer-fighting polymer capsules that they suggest could be used for targeted drug delivery of chemotherapeutics. The team’s work was published in ACS Nano. The multi-layer capsules feature good imaging contrast, as well as efficient encapsulation of doxorubicin, according to the researchers. The vessels are triggered by […]

Filed Under: Drug-Device Combinations, Featured, Nanoparticles, Oncology, Research & Development Tagged With: University of Alabama at Birmingham

Study: Why even targeted lung cancer therapies eventually fail

March 30, 2017 By Sarah Faulkner

Lungs

Even when patients are treated with targeted cancer therapies, many lung cancer patients suffer a recurrence. Researchers at Cold Spring Harbor Laboratory wanted to uncover how some cancers escape the power of targeted treatment. Their work was published in the journal eLife this week. The team of scientists, lead by Raffaella Sordella, found that a tiny subset […]

Filed Under: Featured, Immunotherapy, Oncology, Research & Development Tagged With: Cold Spring Harbor Laboratory

Aura Biosciences wins fast track designation for light-activated nanoparticle therapy

March 30, 2017 By Sarah Faulkner

Aura Biosciences

Aura Biosciences said today that it enrolled and dosed the 1st patient in the Phase Ib trial of its light-activated AU-011 viral nanoparticle conjugate therapy for the treatment of ocular melanoma. The company also said that the FDA granted fast track designation to its targeted treatment, which will give priority review for the company’s New Drug […]

Filed Under: Clinical Trials, Featured, Food & Drug Administration (FDA), Nanoparticles, Oncology, Optical/Ophthalmic, Regulatory/Compliance, Wall Street Beat Tagged With: Aura Biosciences

Researchers develop ‘nano cage’ to study cancer cell growth

March 29, 2017 By Sarah Faulkner

Researchers develop 'nano cage' to study cancer cell growth

Researchers at Kent State University and Kyoto University published work this week describing the genetic factors that help turn healthy cells into cancerous cells. The team’s work was published in Nature Nanotechnology.  “Traditionally, DNA has a 2-strand shape — the double helix — and its purpose is to code the proteins that form life,” co-author Hanbin […]

Filed Under: Featured, Oncology, Research & Development Tagged With: Kent State University, Kyoto University

Study: Laser-activated gold microstructures deliver cargo directly into cells

March 24, 2017 By Sarah Faulkner

Study: Laser-activated gold microstructures deliver cargo directly into cells

Researchers from the Harvard University’s John A. Paulson School of Engineering and Applied Sciences have developed a method to deliver molecules into cells using gold microstructures. The team published their work in ACS Nano. Previous work has been done to deliver drugs or DNA into cells by tricking or forcing open the cell membrane, but the […]

Filed Under: Featured, Oncology, Research & Development Tagged With: Harvard University

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • Interim pages omitted …
  • Page 34
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS